（文章来源：证券日报） 证券日报网讯 8月4日晚间，雪迪龙发布公告称，公司第五届董事会第二十次会议审议通过了《关于对 外投资设立控股子公司的议案》《关于回购股份集中竞价减持计划的议案》。 ...

证券日报网讯 8月4日晚间，雪迪龙发布公告称，公司第五届监事会第十九次会议审议通过了《关于对 外投资设立控股子公司的议案》。 （文章来源：证券日报） ...

Core Viewpoint - The company, Xuedilong (002658.SZ), plans to establish a joint venture named Huazhong Mass Spectrometry (Beijing) Technology Co., Ltd. with Beijing Huairou Hard Technology Innovation Service Co., Ltd. to focus on mass spectrometry technology development [1] Group 1: Joint Venture Details - The joint venture will concentrate on the research and development of common technologies and key components in the mass spectrometry field [1] - The registered capital of the joint venture is set at 10 million yuan, with the company contributing 8 million yuan (80%) and Huairou Hard Technology contributing 2 million yuan (20%) [1]

Key Points - The core viewpoint of the articles revolves around various companies' announcements regarding stock performance, financial results, and strategic initiatives, highlighting both growth opportunities and challenges in their respective sectors. Group 1: Company Announcements - Aowei New Materials will resume trading on August 5, 2025, with no significant changes in its fundamentals, reporting a 12.50% increase in revenue to 784 million yuan but a 32.91% decrease in net profit due to foreign exchange losses [1][1] - Guizhou Moutai has repurchased 3.4517 million shares, totaling 5.301 billion yuan, which will be used for capital reduction [1][1] - China Shipbuilding plans to address dissenting shareholder buyout requests, leading to a suspension of its stock from August 13, 2025 [2] - China Heavy Industry is set to be absorbed by China Shipbuilding, potentially leading to its delisting from the Shanghai Stock Exchange [3] - Leshan Electric will implement a low electricity price policy for residential use starting September 1, 2025, which is expected to reduce its revenue by approximately 16.6 million yuan [4] - Ruikeda has begun small-scale supply of humanoid robot products, projecting sales revenue of about 10 million yuan for 2025 [5] - Fuyuan Pharmaceutical's innovative drug FY101 is still in Phase I clinical trials, with significant uncertainty regarding its success [6] - Lvtong Technology plans to acquire 51% of Damo Semiconductor for 530 million yuan to facilitate its strategic transition to the semiconductor industry [8] - Xizang Tianlu sold shares of China Power Construction for a total of 184 million yuan, expecting a net investment gain of approximately 45.75 million yuan [9] - Howey Group anticipates a net profit increase of 39% to 50% for the first half of 2025, driven by growth in its image sensor products [10] - Yipin Hong's subsidiary has received approval for clinical trials of its innovative drug for endometriosis [11] - Huiyu Pharmaceutical's innovative drug for advanced solid tumors has completed its first patient dosing in Phase I trials [12] - XGIMI Technology is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [13] - Longyang Electronics' HVLP copper foil products are still in the verification stage, with no revenue generated yet [14] - ST Yuancheng's independent director is under investigation for serious violations, but this will not affect the company's operations [15] - Xiling Power is focusing on robot components as a strategic direction, expanding its product development [17] - Shanghai Xiba plans to establish a joint venture with Yuyuan Rare Earth to promote lithium sulfide business development [18] Group 2: Financial Performance - Chiplink Integration reported a revenue of 3.495 billion yuan for the first half of 2025, with a net loss of 170 million yuan, an improvement from a loss of 471 million yuan in the previous year [19] - Liaoning Port's net profit for the first half of 2025 increased by 110.78% to 956 million yuan, with total revenue of 5.693 billion yuan [20] Group 3: Share Buybacks and Holdings - Nanjing Bank's shareholder Nanjing High-Tech increased its stake to 9% by acquiring 750,770 shares [21] - Xuedilong plans to reduce its holdings by up to 1% of the total share capital, amounting to 6.36 million shares [21]

新京报贝壳财经讯 8月4日，雪迪龙公告，公司董事会审议通过了关于回购股份集中竞价减持计划的议 案。公司计划通过集中竞价交易方式减持部分已回购股份，减持数量不超过635.76万股，占公司总股本 的1%。减持实施期限为自公告发布之日起15个交易日之后的三个月内，即从2025年8月27日至2025年11 月27日，减持价格将根据减持时的二级市场价格确定。减持所得资金将用于补充公司日常经营所需的流 动资金。此次减持不会导致公司控制权和总股本发生变化。公司董事会确保信息披露真实、准确、完 整。 ...

格隆汇8月4日丨雪迪龙(002658.SZ)公布，第五届董事会第二十次会议，审议通过了《关于回购股份集 中竞价减持计划的议案》，根据公司于2024年2月7日披露的《关于回购公司股份方案的公告》和《回购 报告书》中的回购股份用途约定，同意公司以集中竞价交易方式减持部分已回购股份，拟减持数量不超 过6,357,609股，即不超过公司总股本1%，减持期间为自本公告发布之日起15个交易日之后三个月内 （即2025年8月27日至2025年11月27日，根据中国证监会及深圳证券交易所相关规定禁止减持的期间除 外，下同），减持价格根据减持时的二级市场价格确定。 ...

Core Viewpoint - The company plans to establish a joint venture, Huazhong Mass Spectrometry (Beijing) Technology Co., Ltd., focusing on mass spectrometry technology development and industry collaboration [1] Group 1: Company Actions - The company will invest 8 million yuan, representing 80% of the registered capital of the new subsidiary, which totals 10 million yuan [1] - The joint venture aims to conduct research and development on common technologies and key components in the mass spectrometry field [1] Group 2: Industry Focus - The new subsidiary will promote the verification, evaluation, and application of new mass spectrometry technologies [1] - The initiative is expected to enhance communication and cooperation within the mass spectrometry industry, contributing to its overall development [1]

Core Viewpoint - The company plans to establish a joint venture, Huazhong Mass Spectrometry (Beijing) Technology Co., Ltd., focusing on mass spectrometry technology development and industry collaboration [1] Group 1: Joint Venture Details - The joint venture will be co-funded with Beijing Huairou Hard Technology Innovation Service Co., Ltd. [1] - The registered capital of the joint venture is set at 10 million yuan, with the company contributing 8 million yuan, representing 80% of the total capital [1] Group 2: Focus Areas - The joint venture will concentrate on the research and development of common technologies and key components in the mass spectrometry field [1] - It aims to validate, evaluate, and promote new mass spectrometry technologies, facilitating industry communication and collaboration [1]

Core Insights - The company Snowy Dragon (SZ 002658) reported that its revenue composition for the year 2024 is 93.16% from instruments and 6.84% from other sources [1] - The company announced plans to establish a joint venture, Huazhong Mass Spectrometry (Beijing) Technology Co., Ltd., in collaboration with Beijing Huairou Hard Technology Innovation Service Co., Ltd. [3] - The new subsidiary will focus on the mass spectrometry technology field, including the development of common technologies and key components, as well as the validation and promotion of new mass spectrometry technologies [3] Revenue Composition - For the year 2024, Snowy Dragon's revenue is primarily derived from instruments, accounting for 93.16% of total revenue, while other sources contribute 6.84% [1] Joint Venture Establishment - Snowy Dragon is partnering with Beijing Huairou Hard Technology Innovation Service Co., Ltd. to create a new subsidiary [3] - The focus of the new subsidiary will be on mass spectrometry technology, aiming to enhance industry collaboration and development [3]

北京雪迪龙科技股份有限公司（下称"公司"）第五届监事会第十九次会议于2025年8 月4日（星期一）下午15:00在公司会议室，以现场与远程视频会议结合的方式召开，公司 于2025年8月4日以通讯方式发出会议通知。会议应出席监事3名，实际出席监事3名，会议 由监事会主席陈华申先生主持，本次会议的召开与表决符合《公司法》、《公司章程》和 《公司监事会议事规则》的有关规定，表决结果真实有效。 二、监事会会议审议情况 与会监事经过认真讨论，审议通过了下述议案： （一）审议通过《关于对外投资设立控股子公司的议案》； 证券代码：002658 股票简称：雪迪龙 公告编号：2025-029 经审核，监事会认为：本次设立控股子公司所需资金为公司自有资金，投资金额为 800 万元，占公司最近一期经审计净资产的 0.31%，不会对公司财务及经营状况产生重大不利 影响，不存在损害公司及全体股东利益的情形。同意公司以自有资金 800 万元与北京怀柔 硬科技创新服务有限公司共同出资设立控股子公司。 北京雪迪龙科技股份有限公司 第五届监事会第十九次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导 ...